Incidence of SARS-CoV-2 during the Omicron wave: Results of a longitudinal serosurvey in Québec, Canada
-
Published:2024-07-26
Issue:
Volume:
Page:
-
ISSN:0008-4263
-
Container-title:Canadian Journal of Public Health
-
language:en
-
Short-container-title:Can J Public Health
Author:
Lewin AntoineORCID, Germain Marc, Bazin Renée, Grégoire Yves, De Serres Gaston, Renaud Christian
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Allen, N., Brady, M., Martin, A. I. C., Domegan, L., Walsh, C., Doherty, L., Riain, U. N., Bergin, C., Fleming, C., & Conlon, N. (2021). Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals. Journal of Infection, 83(4), e9–e10. 2. Bazin, R., Rochette, S., Perreault, J., Fournier, M.-J., Grégoire, Y., Boivin, A., Lewin, A., Germain, M., & Renaud, C. (2023). Evaluation of anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence in a vaccinated population. Infectious Diseases, 55(6), 425–430. 3. Brisson, M., Hardy, M., Gingras, G., Drolet, M., & Laprise, J.-F. (2022). Modélisation de l’impact potentiel des assouplissements des mesures sanitaires sur l’évolution de la COVID-19 dans le Grand Montréal. https://marc-brisson.net/covid19-response/Modelisation-evolution-COVID-19-au-Quebec_MAJ-Rapport18_31-jan-2022.pdf. Accessed 13 Oct 2023. 4. Cauchemez, S., Horby, P., Fox, A., Mai, L. Q., Thanh, L. T., Thai, P. Q., Hoa, L. N. M., Hien, N. T., & Ferguson, N. M. (2012). Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathogens, 8(12), e1003061. 5. Follmann, D., Janes, H. E., Buhule, O. D., Zhou, H., Girard, B., Marks, K., Kotloff, K., Desjardins, M., Corey, L., & Neuzil, K. M. (2022). Antinucleocapsid antibodies after SARS-CoV-2 infection in the blinded phase of the randomized, placebo-controlled mRNA-1273 COVID-19 vaccine efficacy clinical trial. Annals of Internal Medicine, 175(9), 1258–1265.
|
|